Susan Colpoys
Acute Care · New York, NYNPI 1174241293
Payments from drug & device makers
Across 102 payments — averaging $29.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$656
- Abbott$383
- Novartis$357
- Scpharmaceuticals Inc.$269
- Novo Nordisk$175
- Lexicon Pharmaceuticals, Inc.$170
- plus $998 from 14 others
What the payments were for
- Food & beverage$3,008100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 16 | $656 |
| Abbott | 4 | $383 |
| Novartis | 20 | $357 |
| Scpharmaceuticals Inc. | 7 | $269 |
| Novo Nordisk | 3 | $175 |
| Lexicon Pharmaceuticals, Inc. | 8 | $170 |
| Merck | 7 | $166 |
| E.r. Squibb & Sons, L.L.C. | 2 | $166 |
| Bridgebio Pharma, Inc. | 11 | $162 |
| AstraZeneca | 7 | $148 |
| Bayer | 5 | $100 |
| Boston Scientific | 3 | $73 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| Johnson & Johnson | 1 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
| Amgen | 1 | $23 |
| Pfizer | 1 | $22 |
| Endotronix, Inc. | 1 | $18 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOMEMS$361
- JARDIANCE$250
- CAMZYOS$140
- FUROSCIX$101
How this compares
$3,008 in reported general payments places this provider in the 90th percentile of 980 acute care providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 47 | $66,922 |
| JardianceEmpagliflozin | 53 | $63,127 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $42,517 |
| EliquisApixaban | 22 | $38,326 |
| XareltoRivaroxaban | 28 | $18,640 |
| OzempicSemaglutide | 11 | $9,984 |
| Metoprolol Succinate | 65 | $1,264 |
| Torsemide | 54 | $1,253 |
| Spironolactone | 69 | $576 |
| Carvedilol | 22 | $250 |
| Atorvastatin Calcium | 29 | $220 |
| Furosemide | 30 | $191 |
| Omeprazole | 16 | $139 |
| Amlodipine Besylate | 16 | $43 |
| Metoprolol Tartrate | 18 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $357 | $66,92247 claims |
| Boehringer IngelheimJardiance | $656 | $63,12753 claims |
| PfizerEliquis | $22 | $38,32622 claims |
| Johnson & JohnsonXarelto | $27 | $18,64028 claims |
| Novo NordiskOzempic | $175 | $9,98411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 980 acute care providers in New York.
Other acute care in New York
- Daniel VerinaNew York$464K
- Katie WorthingtonNew York$25K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Julie Anne RoldanNew York$10K
- Lauren Dela CruzNew York$9K
- Kristen DonchezNew York$8K
- Tracy Valerie BertizNew York$7K
- Jennifer UllmanNew York$7K
- Sara-Jane DakroubNew York$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.